Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
Tags
Data and Resources
To access the resources you must log in
This item has no data
Item URL
http://data.d4science.org/ctlg/RISIS2OpenData/dedup_wf_001--f0d3e0cc19670c7d6a2223437bb16c29 |
|
Identity
Access Modality
Field | Value |
---|---|
Access Right | not available |
Attribution
Field | Value |
---|---|
Author | Bianchini, Giampaolo |
Author | Kiermaier, Astrid |
Author | Bianchi, Giulia |
Author | Young-Hyuck Im |
Author | Pienkowski, Tadeusz |
Author | Mei-Ching Liu |
Author | Ling-Ming Tseng |
Author | Dowsett, Mitch |
Author | Zabaglo, Lila |
Author | Kirk, Sarah |
Author | Szado, Tania |
Author | Eng-Wong, Jennifer |
Author | Amler, Lukas |
Author | Valagussa, Pinuccia |
Author | Gianni, Luca |
Publishing
Field | Value |
---|---|
Collected From | Datacite |
Hosted By | figshare |
Publication Date | 2017-01-01 |
Publisher | Figshare |
Additional Info
Field | Value |
---|---|
Language | UNKNOWN |
Resource Type | Collection |
keyword | FOS: Health sciences |
keyword | FOS: Biological sciences |
keyword | FOS: Clinical medicine |
system:type | other |
Management Info
Field | Value |
---|---|
Source | https://science-innovation-policy.openaire.eu/search/other?orpId=dedup_wf_001::f0d3e0cc19670c7d6a2223437bb16c29 |
Author | jsonws_user |
Last Updated | 19 December 2020, 14:46 (CET) |
Created | 19 December 2020, 14:46 (CET) |